4:31 PM ET
8-K
Leadership Change
Gain Therapeutics Leadership Change
Gianluca Fuggetta resigned as Senior Vice President of Finance, principal financial officer, and principal accounting officer effective September 30, 2026. Gene Mack, the company's current President and CEO, has been appointed to serve as interim Chief Financial Officer effective October 1, 2026, while the company searches for a permanent replacement.